Plantar Fibromatosis - Clinical Study [US,CA] (Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

RESTRICTIONS

Conversion Point: Valid Form Fill Age Range: 18+ Gender: All GEO: US Only Traffic Allowed: Social, Banner, Native, Push, SEO, Search, Brand Bidding Ask for email No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Study Description: The purpose of this clinical research study is to see how safe and effective an investigational injectable medication is at treating Plantar Fibromatosis. You may qualify to participate if you have plantar fibromatosis in one foot with at least one nodule causing pain. If enrolled, you may receive up to 4 injections (total) of the medication being tested or a placebo into the nodules of your affected foot per treatment cycle. Your total participation may last up to 4 months, and you will be asked to attend 7 doctor's visits. You will complete various diagnostic tests and provide urine and blood samples for laboratory testing. The doctor’s office conducting the study will be able to provide you with more information about the study requirements. Trial-related procedures and study medication will be provided at no cost. Participants who qualify for the study will receive trial-related procedures and study medication at no cost to you or your insurance. Qualifications: - Physician has diagnosed you with plantar fibromatosis, also known as Ledderhose Disease - Only one foot - Cannot have known bleeding disorder or taking a blood thinner - Cannot require full-time use of wheel chair